(NASDAQ: PGEN) Precigen's forecast annual revenue growth rate of 279% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 82.98%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.98%.
Precigen's revenue in 2025 is $4,340,000.On average, 2 Wall Street analysts forecast PGEN's revenue for 2025 to be $2,955,891,366, with the lowest PGEN revenue forecast at $697,256,633, and the highest PGEN revenue forecast at $5,214,526,100. On average, 2 Wall Street analysts forecast PGEN's revenue for 2026 to be $31,746,034,897, with the lowest PGEN revenue forecast at $22,461,198,710, and the highest PGEN revenue forecast at $41,030,871,084.
In 2027, PGEN is forecast to generate $74,350,202,998 in revenue, with the lowest revenue forecast at $74,350,202,998 and the highest revenue forecast at $74,350,202,998.